Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1's effects on key drivers of accelerated aging There are an estimated 400-500 known cases worldwide, including ...

September 27, 2012 — A farnesyltransferase inhibitor originally intended to treat cancer has improved the conditions of all 25 children in a clinical trial for the rapid-aging disorder ...

Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products The agreement will allow ...

Fans of TLC want an explainer for a new show, 'One Day in My Body.' The show features a woman named Tiffany with a rare ...

Children who develop deep wrinkles, stunted growth, and rapidly aging bones and blood vessels as early as 1 to 2 years of age may be suffering from Hutchinson-Gilford Progeria Syndrome (HGPS), a rare ...

Telomir-1 increased survival in a dose-dependent manner, both under basal conditions and even under stress conditions induced by copper and iron—two metal ions known to accelerate aging by generating ...

TOLEDO, Ohio The odds are unbelievable. With only 18 cases in the U.S. and 80 known cases in the entire world, that 80th case is a Whitehouse one-year-old who lives not quite a stone's throw from ...

“The findings highlight miRNA-145-5p and miRNA-27b-3p as potential therapeutic targets to address adipose tissue defects and premature aging in HGPS” “The findings highlight miRNA-145-5p and miRNA-27b ...

Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1’s effects on key drivers of accelerated aging MIAMI, FLORIDA / ACCESS Newswire / June 18, 2025 / Telomir ...

MIAMI, FLORIDA / ACCESS Newswire / June 18, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company focused on reversing biological aging and age-related diseases ...